Comparing the current results to its competitors, Angiodynamics Inc reported Revenue increase in the 4 quarter 2026 by 8.05 % year on year. The sales growth was above Angiodynamics Inc 's competitors' average revenue growth of 7.78 %, achieved in the same quarter.
Angiodynamics Inc 's Comment on Competition and Industry Peers
AngioDynamics operates in markets characterized by rapid technological advancements, scientific developments, and evolving customer needs. The company faces competition from a range of manufacturers, including large firms with diverse business lines and smaller companies with more limited product offerings. Key competitors include Abbott Laboratories, Becton Dickinson, Boston Scientific Corporation, Cook Medical, EDAP TMS, Johnson and Johnson, Medical Components, Inc. (MedComp), Medtronic, Merit Medical, Penumbra, Inc., Philips 8 Healthcare, Profound Medical, Siemens Healthineers, Stryker Corporation, TeleFlex Medical, Terumo Medical Corporation, and Total Vein Systems. AngioDynamics competes based on factors such as product quality, clinical outcomes, ease of use, reliability, physician familiarity, and cost-effectiveness.
With revenue growth of 8.05 % within Overall company, Angiodynamics Inc achieved improvement in market share, within Overall company to approximately 0.15 %. << More on ANGO Market Share.
*Market share is calculated based on total revenue.
September 3, 2024
AngioDynamics, Inc. a prominent medical technology company renowned for its innovations in vascular health, announced on Monday that it has received CE Mark approval in Europe for its Auryon Atherectomy System. This system is particularly significant for the treatment of Peripheral Artery Disease (PAD), which affects millions of people worldwide, impairing blood flow to the limbs and often leading to serious complications.The Auryon System has been developed to address various conditions associated with PAD, notably Critical Limb Ischemia (CLI) and In-Stent Restenosis (ISR). CLI is a severe form of PAD characterized by significantly reduced blood flow, putting patients at risk of amputation and other serious...
February 15, 2024
AngioDynamics Announces $45 Million Sale of PICC and Midline Product Portfolios to Spectrum Vascular, Completes Patient Enrollment in APEX-AV StudyIn a significant strategic move, AngioDynamics, Inc. (NASDAQ: ANGO), an influential medical technology company specializing in enhancing blood flow, cancer treatment advancements, and improving the overall quality of patients lives, has successfully concluded the sale of its PICC and Midline product portfolios to Spectrum Vascular for a substantial sum of up to $45 million. Spectrum Vascular, a forward-thinking medical device enterprise focused on vascular access and medication management, is set to further enhance its position in the market with this acquisition...
Merit Medical Systems Inc operates as a medical device company that develops, manufactures, and distributes disposable medical devices. Their business model focuses on delivering high-quality and innovative products to healthcare professionals and hospitals worldwide. They generate revenue through the sales and distribution of their medical devices, aiming to improve patient outcomes and provide value to healthcare providers.
Meihua International Medical Technologies Co Ltd Share Performance
-85.00%
One Year
Meihua International Medical Technologies Co Ltd
Profile
Meihua International Medical Technologies Co. Limi operates on a business model focused on the development and distribution of medical technologies and solutions. The company aims to deliver innovative and quality medical equipment to healthcare providers and institutions globally. By leveraging their expertise and partnerships, Meihua strives to enhance healthcare outcomes and contribute to the advancement of medical technology.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Lemaitre Vascular Inc is a medical device company specializing in the design, development, and distribution of innovative medical devices for the treatment of peripheral vascular disease. Their business model revolves around creating and manufacturing high-quality products that address specific needs in the field of vascular surgery. They leverage a combination of direct sales, distribution partnerships, and ongoing research and development efforts to effectively reach healthcare professionals and provide comprehensive solutions for patients.
Sources:
Angiodynamics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Angiodynamics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
